User Manual

Panorama™ Operating Instructions 0070-10-0690-01 xi
Warnings, Precautions and Notes Introduction
WARNING: The Telepack should not be used adjacent to or stacked with
other equipment. If adjacent or stacked use is necessary, the
Telepack should be observed to verify normal operation in
the configuration in which it will be used.
WARNING: The Telepack with Nonin SpO
2
module should only be used
with Nonin-manufactured PureLight
®
pulse oximeter
sensors. Using other manufacturers’ sensors can result in
inaccurate pulse oximeter performance.
WARNING: Do not use the Telepack with Nonin SpO
2
module in an
explosive atmosphere or in the presence of flammable
anesthetics or gases.
WARNING: Loss of SpO
2
monitoring when using the Telepack with
Nonin SpO
2
module can result if any objects hinder the
pulse measurement. Ensure that no blood flow restrictions
(e.g. blood pressure cuff) hinder pulse measurements.
WARNING: The Telepack with Nonin SpO
2
module does not meet
defibrillation-proof requirement per IEC 60601-1: 1990,
clause 17.h.
WARNING: Operation of the Telepack with Nonin SpO
2
module below
the minimum amplitude of 0.3% modulation may cause
inaccurate SpO
2
results.
WARNING: Do not use the Telepack and/or the Telepack with Nonin
SpO
2
module during MRI (Magnetic Resonance Imaging)
scanning. Induced current could potentially cause burns.
Accuracy of measurements on this unit and the MRI unit
may also be affected.
WARNING: Do not use a damaged SpO
2
sensor.
WARNING: To use accessories, sensors, and cables other than those
specified by Datascope (except transducers and cables sold
by Datascope as replacement parts for internal components)
may result in increased emission and/or decreased
immunity of this device.
WARNING: This equipment/system is intended for use by healthcare
professionals only. This equipment/system may cause radio
interference or may disrupt the operation of nearby
equipment. It may be necessary to take mitigation
measures, such as reorienting or relocating the
equipment/system or shielding the location.
WARNING: As with all medical equipment, carefully route cables and
connections to reduce the possibility of entanglement or
strangulation.
WARNING: PACEMAKER PATIENTS - Indication of the heart-rate may be
adversely affected by cardiac pacemaker pulses or by
cardiac arrhythmias. Keep pacemaker patients under close
surveillance. Refer to ‘‘ECG Performance Requirements’’ on
page 16-2 for disclosure of the pacer rejection capability.
WARNING: PACEMAKER PATIENTS - Rate meters may continue to count
the pacemaker rate during occurrences of cardiac arrest or
some arrhythmias. Do not rely entirely upon rate meter
alarms. Keep pacemaker patients under close surveillance.